Clinical Trial Update: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial evaluating the immunogenicity and safety of a hexavalent vaccine that contains a reduced-dose inactivated poliovi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Hexavalent DTaP-HBV-IPV-Hib vaccine (reduced-dose IPV) (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Haemophilus influenzae type b, and inactivated Poliovirus vaccine)

Snippet

Sponsor: Serum Institute of India Pvt. Ltd. | Conditions: Diptheria Immunization, Tetanus Immunization | Phase 3 | Status: RECRUITING